519.00USD-3.92%Mkt Cap: 12.48B $P/E: —Today
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directe…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap12.48B $
Enterprise Value11.50B $
Revenue (TTM)1.28B $
Gross Profit902.25M $
Net Income (TTM)-288.28M $
Revenue/Share56.15 USD
Last Price519.00 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees915
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS5588681057
Valuation
P/E (Trailing)—
P/E (Forward)53.93
PEG—
EV/EBITDA-35.82
EV/Revenue8.96
P/S9.34
P/B22.89
EPS (TTM)-13.43
EPS (Forward)9.63
52W Range
351.3264% of range615.00
52W High615.00 USD
52W Low351.32 USD
Profitability
Gross Margin94.14%
Oper. Margin-15.46%
EBITDA Margin-25.01%
Profit Margin-30.08%
ROE-47.83%
ROA-22.89%
Growth
Revenue Growth71.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-189.55M $
CapEx (TTM)3.47M $
FCF Margin-6.27%
FCF Yield-0.64%
Net Debt-491.00M $
Net Debt/EBITDA1.53
Balance Sheet
Debt/Equity0.58
Current Ratio3.21
Quick Ratio2.75
Book Value/Sh22.68 USD
Cash/Share36.30 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 25, 2016
Splits
Last Split1:35
Split DateJul 25, 2016
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)678.06 USD
Upside (mean)+30.6%
Target Range543.00 USD – 962.00 USD
$543.00+30.6% to mean$962.00
# Analysts16
Ownership
Shares Out.23.10M
Float13.73M
Insiders5.87%
Institutions104.41%
Short Interest
Short Ratio5.4d
Short % Float10.00%
Short % Out.8.51%
Shares Short1.97M
Short (prev mo.)3.53M
Technical
SMA 50521.92 (-0.6%)
SMA 200513.34 (+1.1%)
Beta-1.00
S&P 52W Chg18.16%
Avg Vol (30d)340.93K
Avg Vol (10d)299.36K
Technical Indicators
RSI (14)55.7
MACD-0.1562
MACD Signal-1.8866
MACD Hist.+1.7304
BB Upper566.77 USD
BB Middle520.69 USD
BB Lower474.61 USD
BB Width17.70%
ATR (14)22.54 USD
Vol Ratio (20d)0.59x